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DISCUSSION: FRANCIS L. BLACK*
I wish Dr. Francisco Duran-Reynals could be here today to hear
Dr. Habel's presentation. For 20 years Dr. Duran-Reynals worked here at
Yale to try to convince the world of the significance of viruses in the
etiology of cancer. Few listened, and at the time his work must have seemed
unappreciated; but through those few listeners his labors have borne much
fruit. I am sure he would take great pleasure today in seeing the point to
which the knowledge of tumor viruses has advanced. In particular,
Dr. Habel's important studies on the immunological factors in viral
oncogenicity form a fitting sequel to Dr. Duran-Reynals' studies on Rous
sarcoma.1
Dr. Habel has pointed out the epidemiological significance of immune
reactions to tumor antigens: the special susceptibility of the young, immuno-
logically immature animal means that we must look for the initial infection
in very early life, quite possibly, as in rubella, long before birth.
There are other epidemiological implications in this presentation that
deserve attention. Polyoma virus acquired its name from the fact that
it may cause a wide variety of tumors in various organs. If we are to look
for patterns of viral carcinogenesis in man, we must be alert to patterns that
cross the conventional classifications of tumors. Polyoma, in high titer, will
cause death within a few days, sometimes due to kidney tumors and, under
other circumstances, to hemorrhages in the liver caused by minute endo-
theliomas. In lower titer, polyoma usually causes relatively benign tumors
at the site of injection that become recognizable only in adult life and may
then grow to enormous size before causing death. The suggestion that
Burkitt's lymphoma of the jaw and childhood leukemia may have a common
etiology is in line with the concept of multiple forms of cancer with a single
primary cause. We must be alert to other such interrelationships between
histologically diverse tumors. The common classification of cancer by site
may be quite inadequate for epidemiological analysis.
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Dr. Habel has also pointed up facts that support an old adage of Dr.
Duran-Reynals: failure to demonstrate infectious virus in a tumor does not
mean that a virus was not involved. Although polyoma virus seems to cause
the critical change to malignancy very rapidly, the tumor may not reach
recognizable size until after an animal, infected at birth, has reached adult-
hood and long after all infectious virus has been eliminated. It is difficult
to know how to apply this time scale to man with his much extended growth
period, but we must look for correlations with infections occurring long
before the tumor appears.
TABLE 1. EFFECT OF IUdR ON POLYOMA TUMORS IN NEONATAL HAMSTERS
Virus dilution
Drug 10-0 10-1 10-2 10-3
Tumors 17 20 11 9
Saline Total 17 20 13 17
Per cent 100 100 85 53
Tumors 5 3 2 1
IUdR 0.5 mg. Total 5 13 12 18
per day
xp 1 Per cent 100 23 17 6
Dr. Habel has suggested that at least a portion of the DNA of polyoma
virus may persist in the tumor cell. This persisting viral DNA may either
obviate normal growth-repressor mechanisms or contribute new and
uncontrolled shortcuts to cell growth. In either case it seemed possible that
the changed metabolism would have a differential sensitivity to inhibitors
of DNA synthesis and that control might be re-established through the use
of such drugs. Huebner and his co-workers found evidence of such an
effect on adenovirus tumors in hamsters.2 Working in a cooperative project
with Drs. Fischer and Welch' we have studied the effect of a number of
these drugs on the development of polyoma tumors. One example of the
effect found is given in Table 1. The drug 5-iodo-uridine-desoxyriboside
reduced the oncogenic titer of polyoma by more than tenfold. To achieve
this effect it was necessary to maintain treatment for several days. This
was true even though our schedule was insufficient to maintain constant
blood levels. The animals showed no sign of toxicity at this level of drug
and grew normally.
Finally, I would like to assure the audience that, though we may some-
times talk as if we believed viruses were the only cause of cancer, most
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virologists are aware that other factors are involved. I believe that, in
Dr. Habel's presentation, we find a transition between the virus papers
of the morning and the chronic disease papers of the afternoon. Non-
microbiological factors are important in oncogenesis involving the viruses
and viral or other infectious agents may play roles in many diseases
presently referred to as "chronic" or "noninfectious."
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